Cargando…
Metyrapone, an inhibitor of cytochrome oxidases, does not affect viability in a neuroblastoma cell model of bilirubin toxicity
BACKGROUND: Unconjugated hyperbilirubinemia may cause brain damage in infants, and globally remains a source of neonatal morbidity and mortality. A significant inter-individual variability in vulnerability to bilirubin toxicity remains largely unexplained. An enzyme located in mitochondria oxidizes...
Autores principales: | Naguib Leerberg, Maria N., Alme, Tomas N., Hansen, Thor W.R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121316/ https://www.ncbi.nlm.nih.gov/pubmed/27896088 http://dx.doi.org/10.1016/j.ymgmr.2014.04.002 |
Ejemplares similares
-
Metyrapone: Various toxicities: case report
Publicado: (2021) -
Effect of bilirubin on cytochrome c oxidase activity of mitochondria from mouse brain and liver
por: Malik, Safarina G, et al.
Publicado: (2010) -
Metyrapone for Long-Term Medical Management of Cushing's Syndrome
por: Traina, Andrea N., et al.
Publicado: (2013) -
Cushing Disease Treated Successfully With Metyrapone During Pregnancy
por: Bass, Ilana Ramer, et al.
Publicado: (2021) -
Maternal Metyrapone Use During Breastfeeding: Safe for the Breastfed Infant
por: Duke, Madeline E, et al.
Publicado: (2019)